Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Distant metastasis is the primary cause of treatment failure in locoregionally advanced nasopharyngeal carcinoma (LANPC).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To develop a model to evaluate distant metastasis‐free survival (DMFS) in LANPC and to explore the value of additional chemotherapy to concurrent chemoradiotherapy (CCRT) for different risk groups.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 233 patients with biopsy‐confirmed nasopharyngeal carcinoma (NPC) from two hospitals.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength</h3><p>1.5T and 3T.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Sequence</h3><p>Axial T<sub>2</sub>‐weighted (T<sub>2</sub>‐w) and contrast‐enhanced T<sub>1</sub>‐weighted (CET<sub>1</sub>‐w) images. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Deep learning was used to build a model based on MRI images (including axial T<sub>2</sub>‐w and CET<sub>1</sub>‐w images) and clinical variables. Hospital 1 patients were randomly divided into training (<i>n = </i> 169) and validation (<i>n = </i> 19) cohorts; Hospital 2 patients were assigned to a testing cohort (<i>n = </i> 45). LANPC patients were divided into low‐ and high‐risk groups according to their DMFS (<i>P </i> < 0.05). Kaplan–Meier survival analysis was performed to compare the DMFS of different risk groups and subgroup analysis was performed to compare patients treated with CCRT alone and treated with additional chemotherapy to CCRT in different risk groups, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Univariate analysis was performed to identify significant clinical variables. The area under the receiver operating characteristic (ROC) curve (AUC) was used to assess the model performance.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Our deep‐learning model integrating the deep‐learning signature, node (N) stage (from TNM staging), plasma Epstein–Barr virus (EBV)‐DNA, and treatment regimens yielded an AUC of 0.796 (95% confidence interval [CI]: 0.729–0.863), 0.795 (95% CI: 0.540–1.000), and 0.808 (95% CI: 0.654–0.962) in the training, internal validation, and external testing cohorts, respectively. Low‐risk patients treated with CCRT alone had longer DMFS than patients treated with additional chemotherapy to CCRT (<i>P </i> < 0.05). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The proposed deep‐learning model, based on MRI features and clinical variates, facilitated the prediction of DMFS in LANPC patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>4.</p></section>

Deep learning pathological microscopic features in endemic nasopharyngeal cancer: Prognostic value and protentional role for individual induction chemotherapy

1164PDevelopment and validation a nomogram based on pathological microscopic features to predict survival in nasopharyngeal carcinoma and guide treatment decision

Development and validation a nomogram based on pathological microscopic features to predict survival in nasopharyngeal carcinoma and guide treatment decision

A Deep-Learning-Based Prognostic Nomogram Integrating Microscopic Digital Pathology And Macroscopic Magnetic Resonance Images In Nasopharyngeal Carcinoma: A Multi-Cohort Study

The prognostic value of deep learning-based percentage of tumour-infiltrating lymphocytes in nasopharyngeal carcinoma.

Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network

Deep convolution neural network model for automatic risk assessment of patients with non-metastatic nasopharyngeal carcinoma

A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study

Progression-Free Survival Prediction in Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy: Machine Learning vs. Traditional Statistics

Computer-Aided Pathologic Diagnosis of Nasopharyngeal Carcinoma Based on Deep Learning

Abstract 5430: Deep Learning-Based Prognosis Prediction in T3N1 Nasopharyngeal Carcinoma Patients Treated with Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

Prediction of 5-year Progression-Free Survival in Advanced Nasopharyngeal Carcinoma with Pretreatment PET/CT using Multi-Modality Deep Learning-based Radiomics

Integrative Scoring System for Survival Prediction in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Multicenter Study

A Prognostic and Predictive Model Based on Deep Learning to Identify Optimal Candidates for Intensity-Modulated Radiotherapy Alone in Patients with Stage II Nasopharyngeal Carcinoma: A Retrospective Multicenter Study

Machine learning-derived prognostic signature for progression-free survival in non-metastatic nasopharyngeal carcinoma

Deep learning for risk prediction in patients with nasopharyngeal carcinoma using multi-parametric MRIs

The Efficacy of Pretreatment 18F-FDG PET-CT-Based Deep Learning Network Structure to Predict Survival in Nasopharyngeal Carcinoma

A Clinical-Radiomics Nomogram Based on Magnetic Resonance Imaging for Predicting Progression-Free Survival After Induction Chemotherapy in Nasopharyngeal Carcinoma

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

MRI‐Based Deep‐Learning Model for Distant Metastasis‐Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma